CEBIO
Joining biomarkers
and data science
for better health
HOW WE CAN ASSIST YOU
- cfDNA from various cancer cell lines
- Customizable cfDNA profiles
- Tailored for applications in Liquid Biopsies
- Assay development and evaluation
- Analytical and preanalytical studies
- Comprehensive lab services
- Translational biomarker studies
- Study design, organization & logistics
- Platform for clinical data documentation
- Established and new biomarkers (DNA, RNA, exosomes)
- Multi-omics technologies
- Biobank sample logistics and network
- Documentation & plausibility checks
- Software & local adaptation
- On site evaluation & cloud solutions
- Certified & professional biostatistics
- Multimarker & Individual modelling
- Machine learning & Artificial Intelligence
WHAT DISTINGUISHES US
Interconnectivity
Connecting specialists from all fields of biomarker research and application from clinics, lab doctors, research and pharma
Interdisciplinarity
Using the best knowledge of many disciplines to bring biomarker research and evaluation on a new level
Expertise and Experience
Longterm experience of CEBIO founders in biomarker research, lab analytics, biobanking, biostatistics and data science
OUR MISSION
CEBIO leverages the full power
of high quality biomarkers for patient care
Above all we are an interdisciplinary network of specialists for lab, clinics, biobanking, biostatistics and data science.
APPLICATIONS / PROJECTS
Clinics
Performing high quality biomarker studies and providing study logistics for body fluid sample collection.
Examples:
- CESAR-CEPAC tumor marker study
- Metabolomic lung cancer biomarker study
- Proteomic lung cancer biomarker study
- Exosomal miRNA in colorectal cancer
Research
Investigating biological biomarker networks, leveraging the power of new technologies and providing high quality evaluation of new assays
Examples:
- Development of a SPR miRNA platform
- Soluble PD1-markers in lung cancer monitoring
- Multiplex biomarker technologies for cancer detection
Pharma Diagnostics
Analyzing the analytical and preanalytical quality of your biomarkers, testing the clinical utility of your biomarkers and developing proficiency testing schemes
Examples:
- Proficiency testing system for SARS-CoV-2 PCR Testing (Merck)
Pharma Therapeutics
Speeding up the development of therapies by precise monitoring of biochemical response and choosing the right therapy by the best companion diagnostics
Examples:
- Metaanalysis of lung cancer markers for predicting therapy response